Bert Vogelstein to present on “Translational Implications of Colorectal Cancer Genetics” at GTCbio’s 3rd International Conference on Tumor Progression & Therapeutic Resistance.
August 28, 2006 (Press Release) --
MONROVIA- GTCbio today announced that Bert Vogelstein, MD, Professor of Oncology and Pathology at Johns Hopkins University, will be giving the Keynote Address at this year’s Tumor Progression & Therapeutic Resistance Conference. The conference is being held October 22-24, 2006 at the Radisson Plaza Lord Baltimore in Baltimore Maryland.
Dr. Vogelstein’s work has influenced cancer revolution. Among being a professor at Johns Hopkins University, Dr. Vogelstein is an investigator of the Howard Hughes Medical Institute and is most well known as a pioneer in cancer research. He has received several prestigious awards throughout his career, including the Gairdner Foundation International Award, Louisa Gross Horwitz Prize, Prince of Asturias Award for Technical and Scientific Research, and other awards for his research. His presentation, entitled “Translational Implications of Colorectal Cancer Genetics”, will take place on the morning of October 22.
The 3 day event will also feature over 40 speakers from Harvard, Yale, NCI/NIH, University of Pennsylvania, MD Anderson Cancer Center, UT Southwestern, Columbia, Salk Institute, Stanford, Georgetown University, Case Western Reserve, Northwestern, Fred Hutchinson Cancer Research Center, Karmanos Cancer Inst., UCSF, Novartis, GSK, Tgen, Genzyme, Morphotek, and more.
This year’s conference is sponsored in part by Abramson Cancer Center at the University of Pennsylvania, Pfizer, Landes Bioscience and Cancer Cell.
More information including a detailed agenda, exhibitor opportunities and registration information can be found at http://gtcbio.com/confpage.asp?cid=14.
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, infogtcbio@gtcbio.com
Dr. Vogelstein’s work has influenced cancer revolution. Among being a professor at Johns Hopkins University, Dr. Vogelstein is an investigator of the Howard Hughes Medical Institute and is most well known as a pioneer in cancer research. He has received several prestigious awards throughout his career, including the Gairdner Foundation International Award, Louisa Gross Horwitz Prize, Prince of Asturias Award for Technical and Scientific Research, and other awards for his research. His presentation, entitled “Translational Implications of Colorectal Cancer Genetics”, will take place on the morning of October 22.
The 3 day event will also feature over 40 speakers from Harvard, Yale, NCI/NIH, University of Pennsylvania, MD Anderson Cancer Center, UT Southwestern, Columbia, Salk Institute, Stanford, Georgetown University, Case Western Reserve, Northwestern, Fred Hutchinson Cancer Research Center, Karmanos Cancer Inst., UCSF, Novartis, GSK, Tgen, Genzyme, Morphotek, and more.
This year’s conference is sponsored in part by Abramson Cancer Center at the University of Pennsylvania, Pfizer, Landes Bioscience and Cancer Cell.
More information including a detailed agenda, exhibitor opportunities and registration information can be found at http://gtcbio.com/confpage.asp?cid=14.
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, infogtcbio@gtcbio.com
Email
Print
SPAM
